image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 5.84
-0.336 %
$ 2.27 B
Market Cap
-65.89
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one LFST stock under the worst case scenario is HIDDEN Compared to the current market price of 5.84 USD, LifeStance Health Group, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one LFST stock under the base case scenario is HIDDEN Compared to the current market price of 5.84 USD, LifeStance Health Group, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one LFST stock under the best case scenario is HIDDEN Compared to the current market price of 5.84 USD, LifeStance Health Group, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart LFST

image
$8.5$8.5$8.0$8.0$7.5$7.5$7.0$7.0$6.5$6.5$6.0$6.0$5.5$5.5$5.0$5.015 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '25
FINANCIALS
1.25 B REVENUE
18.50%
-31.6 M OPERATING INCOME
83.29%
-57.4 M NET INCOME
69.16%
107 M OPERATING CASH FLOW
735.28%
-21.6 M INVESTING CASH FLOW
64.26%
-9.95 M FINANCING CASH FLOW
-20.97%
333 M REVENUE
2.30%
1.6 M OPERATING INCOME
51.46%
709 K NET INCOME
109.97%
-3.09 M OPERATING CASH FLOW
-4.96%
-7.17 M INVESTING CASH FLOW
-13.76%
-9.98 M FINANCING CASH FLOW
-145.75%
Balance Sheet LifeStance Health Group, Inc.
image
Current Assets 313 M
Cash & Short-Term Investments 155 M
Receivables 132 M
Other Current Assets 25.9 M
Non-Current Assets 1.81 B
Long-Term Investments 0
PP&E 314 M
Other Non-Current Assets 1.49 B
7.30 %6.23 %14.82 %70.43 %Total Assets$2.1b
Current Liabilities 229 M
Accounts Payable 7.24 M
Short-Term Debt 56.7 M
Other Current Liabilities 165 M
Non-Current Liabilities 443 M
Long-Term Debt 428 M
Other Non-Current Liabilities 14.6 M
8.44 %24.54 %63.76 %Total Liabilities$672.0m
EFFICIENCY
Earnings Waterfall LifeStance Health Group, Inc.
image
Revenue 1.25 B
Cost Of Revenue 849 M
Gross Profit 402 M
Operating Expenses 434 M
Operating Income -31.6 M
Other Expenses 25.8 M
Net Income -57.4 M
1b1b1b1b1b1b800m800m600m600m400m400m200m200m00(200m)(200m)1b(849m)402m(434m)(32m)(26m)(57m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
32.17% GROSS MARGIN
32.17%
-2.53% OPERATING MARGIN
-2.53%
-4.59% NET MARGIN
-4.59%
-3.97% ROE
-3.97%
-2.71% ROA
-2.71%
-1.62% ROIC
-1.62%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis LifeStance Health Group, Inc.
image
100m100m80m80m60m60m40m40m20m20m00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)202020202021202120222022202320232024202420252025
Net Income -57.4 M
Depreciation & Amortization 71 M
Capital Expenditures -21.6 M
Stock-Based Compensation 0
Change in Working Capital -27.4 M
Others 85.8 M
Free Cash Flow 85.7 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets LifeStance Health Group, Inc.
image
Wall Street analysts predict an average 1-year price target for LFST of $8.5 , with forecasts ranging from a low of $8.5 to a high of $8.5 .
LFST Lowest Price Target Wall Street Target
8.5 USD 45.55%
LFST Average Price Target Wall Street Target
8.5 USD 45.55%
LFST Highest Price Target Wall Street Target
8.5 USD 45.55%
Price
Max Price Target
Min Price Target
Average Price Target
998888777766665555Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership LifeStance Health Group, Inc.
image
Sold
0-3 MONTHS
34.4 K USD 1
3-6 MONTHS
394 K USD 2
6-9 MONTHS
644 K USD 2
9-12 MONTHS
815 K USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Wall Street Analysts Think LifeStance Health (LFST) Could Surge 45.04%: Read This Before Placing a Bet The consensus price target hints at a 45% upside potential for LifeStance Health (LFST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com - 2 weeks ago
LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 46th Annual Goldman Sachs Healthcare Conference, which will be hosted in Miami, Florida. globenewswire.com - 3 weeks ago
Live Nasdaq Composite: Market Optimism Returns Amid EU Tariff Delay Live Updates Live Coverage Has Ended Goldman Bullish on Nuclear Stocks 12:05 pm by Gerelyn Terzo Goldman Sachs is bullish on two nuclear stocks – Cameco (NYSE: CCJ) and NuScale Power (NYSE: SMR) – saying they are poised to benefit from the Trump administration’s friendly regulation. Both stocks have rallied by double-digit percentages in recent days. President Trump is determined to bolster domestic uranium production, send advanced reactors to military and energy sites, and tighten the window for new reactor license approvals to 18 months, a process that traditionally is infamous for being extremely lengthy. The markets are holding their gains, including a 2.1% advance in the Nasdaq Composite. Consumer Confidence Soars 10:35 am by Gerelyn Terzo Consumer Confidence surged in May, hitting 98 – a significant 12.3-point jump from April. This robust reading defied economists’ predictions of 86, despite ongoing tariff concerns. The markets are widening their lead, including a nearly 2% jump in the Nasdaq Composite. Durable Goods Orders Reverse 9:55 am by Gerelyn Terzo Durable goods orders fell 6.3% last month, a narrower decline than economists had anticipated but on the heels of four straight monthly increases. The latest data is a gauge on business spending in light of the tariffs. Boeing (NYSE: BA) orders were a drag, falling 51% last month. This article will be updated throughout the day, so check back often for more daily updates. Optimism has seeped back into the markets, with all three of the major stock market averages coming out of the gate higher. President Trump announced a pause on proposed EU tariffs until July 9, fueling a 300-point gain in the Dow Jones Industrial Average. Technology stocks are leading the Nasdaq Composite and S&P 500 each higher by over 1%. The proposed EU import tariff continues to hover at 50%, and July isn’t too far away, but for now, the markets are seeing the glass as half full. The Trump administration’s deal with the EU suggests further trade partner progress could be revealed sooner than later. Wall Street firm Piper Sandler has reiterated its “overweight” rating on Nvidia (Nasdaq: NVDA) stock ahead of the AI darling’s highly anticipated quarterly results due out tomorrow, advising investors to stay long on the stock and weather the uncertainty because the worst is behind them. Other Mag 7 stocks are higher today as well, including Meta Platforms (Nasdaq: META) and Amazon (Nasdaq: AMZN), each with a 1% jump. Tesla (Nasdaq: TSLA) is rallying 3.5% after Wedbush analysts labeled the EV maker an AI “pure play” and lifted the price target to $500 per share. Here’s a look at the performance as of morning trading: Dow Jones Industrial Average: Up 378.17 (+0.89%) Nasdaq Composite: Up 275.40 (+1.5%) S&P 500: Up 65.67 (+1.1%) Market Movers UBS has upgraded shares of LifeStance Health (Nasdaq: LFST) to a “buy” rating from “neutral” on a bullish long-term outlook, sending the stock up 4%. Data analytics software stock Palantir Technologies (Nasdaq: PLTR) is gaining 2% on the day in the tariff-fueled rally. Southwest Airlines (NYSE: LUV) will begin charging customers $35 for the first checked bag and $45 for the second later this week, a reversal of a longstanding “bags fly free” policy for the airline. The markets are rewarding LUV stock for the added revenue with a 3% advance. The post Live Nasdaq Composite: Market Optimism Returns Amid EU Tariff Delay appeared first on 24/7 Wall St.. https://247wallst.com - 3 weeks ago
S&P 500 (NYSEARCA: SPY) Live: Markets Upbeat on EU Tariff Surprise and Resilient Economy Live Updates Live Coverage Has Ended Wall Street Endorses Nuclear Stocks 12:10 pm by Gerelyn Terzo Goldman Sachs has issued a bullish report on a pair of nuclear stocks – Cameco (NYSE: CCJ) and NuScale Power (NYSE: SMR) – pointing to regulatory tailwinds from the Trump administration. Both stocks have risen by double-digit percentages since President Trump issued an executive order last week. The president is determined to bolster domestic uranium production, send advanced reactors to military and energy sites, and shorten the wait for new reactor license approvals to one and a half years, a process that historically is known for moving at a snail’s pace. Business Orders Soften 10:30 am by Gerelyn Terzo Durable goods orders posted a 6.3% decline last month, a softer drop than economists had predicted. However, this dip follows four consecutive months of increases, painting a mixed picture for business spending amid ongoing tariff discussions. A significant drag on the overall figures was Boeing (NYSE: BA), whose orders plunged 51% last month. This article will be updated throughout the day, so check back often for more daily updates. Market sentiment has turned decidedly upbeat, with all three major stock market averages seeing gains from the open. President Trump agreed to delay proposed EU tariffs until July 9, which led to a 300-point jump for the Dow Jones Industrial Average. Also buoying stocks is the latest round of economic data. Consumer Confidence for May came in at a stronger than expected reading of 98, up 12.3 points month-over-month. Economists were calling for a reading of 86 in the face of tariffs. The SPDR S&P 500 ETF (SPY) is gaining 1.45% on the day. Technology stocks powering the Nasdaq Composite and S&P 500 up by over 1% each. Despite the pending 50% EU import tariff and July being right around the corner, markets are satisfied with the interim relief, viewing the Trump administration’s agreement with the EU as a potential precursor to further positive trade developments. Wall Street firm Piper Sandler has reiterated its “overweight” rating on Nvidia (Nasdaq: NVDA) ahead of the AI darling’s crucial quarterly results tomorrow. The firm suggests investors hold fast, believing the most challenging period is now behind the company. Other “Magnificent Seven” members are also enjoying gains, with Meta Platforms (Nasdaq: META) and Amazon (Nasdaq: AMZN) both up 1%. Tesla (Nasdaq: TSLA) stands out with a 3.5% rally after Wedbush analysts elevated the EV manufacturer to an AI “pure play” and boosted its price target to $500 per share. Here’s a look at the performance as of morning trading: Dow Jones Industrial Average: Up 488.43 (+1.1%) Nasdaq Composite: Up 376.43 (+2.0%) S&P 500: Up 90.11 (+1.5%) Market Movers UBS has upgraded LifeStance Health (Nasdaq: LFST) to a “buy” from “neutral” on a positive long-term forecast, sending the stock up 4%. Data analytics software specialist Palantir Technologies (Nasdaq: PLTR) is also up 2% today, riding the broader tariff-driven rally. Southwest Airlines (NYSE: LUV) will soon begin charging customers $35 for the first checked bag and $45 for the second, abandoning its signature “bags fly free” policy. This strategic move is being rewarded by investors, with LUV stock gaining 3%. The post S&P 500 (NYSEARCA: SPY) Live: Markets Upbeat on EU Tariff Surprise and Resilient Economy appeared first on 24/7 Wall St.. https://247wallst.com - 3 weeks ago
LifeStance Names Vaughn Paunovich as Chief Technology Officer SCOTTSDALE, Ariz. , May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. prnewswire.com - 1 month ago
LifeStance Health Group, Inc. (LFST) Q1 2025 Earnings Call Transcript LifeStance Health Group, Inc. (NASDAQ:LFST ) Q1 2025 Results Conference Call May 7, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ryan McGroarty - CFO David Bourdon - CEO Conference Call Participants Craig Hettenbach - Morgan Stanley Jamie Perse - Goldman Sachs Ryan Daniels - William Blair Brian Tanquilut - Jefferies Richard Close - Canaccord Genuity Dylan Christopher - UBS Steven Dechert - KeyBanc Capital Markets Operator Good day, everyone, and thank you for standing by. My name is Arji, and I will be your conference operator today. seekingalpha.com - 1 month ago
LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com - 1 month ago
Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. zacks.com - 1 month ago
LifeStance Health Group (LFST) Reports Break-Even Earnings for Q1 LifeStance Health Group (LFST) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.06 per share a year ago. zacks.com - 1 month ago
LifeStance Reports First Quarter 2025 Results SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2025. globenewswire.com - 1 month ago
Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 28.68%: Here's is How to Trade The mean of analysts' price targets for LifeStance Health (LFST) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. zacks.com - 1 month ago
LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 1 month ago
8. Profile Summary

LifeStance Health Group, Inc. LFST

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 2.27 B
Dividend Yield 0.00%
Description LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Contact 4800 N. Scottsdale Road, Scottsdale, AZ, 85251 https://www.lifestance.com
IPO Date June 10, 2021
Employees 7535
Officers Mr. Kenneth Alan Burdick Executive Chairman Mr. Ryan Pardo J.D. Chief Legal Officer & Secretary Ms. Ann Varanakis Chief People Officer Mr. Richard Hall Executive Vice President of Shared Services Mr. David Patrick Bourdon Chief Executive Officer & Director Ms. Monica Prokocki Vice President of Investor Relations Brooke Matthews Director of Public Relations Dr. Ujjwal Ramtekkar CPE, M.B.A., M.D. Chief Medical Officer Mr. Ryan Bruce McGroarty Chief Financial Officer & Treasurer Mr. Pablo Pantaleoni Chief Digital Officer